Medicare Enrolled
Dr. Alaa Kubbar, MD
Endocrinology · Fall River, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kubbar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kubbar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kubbar
Dr. Alaa Kubbar is an endocrinology specialist in Fall River, MA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Kubbar performed 2,562 Medicare services across 1,795 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kubbar received a total of $2,831 from 25 pharmaceutical and/or device companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kubbar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 13% volume in MA
$2,831 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,562
Medicare services
Top 13% in MA for endocrinology
1,795
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~285 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $87 | $370 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
270 | $3 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
257 | $64 | $230 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
204 | $8 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
149 | $61 | $250 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
129 | $9 | $31 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
126 | $16 | $58 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
113 | $8 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $136 | $638 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
93 | $40 | $125 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
83 | $10 | $40 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
80 | $26 | $113 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
60 | $29 | $99 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
58 | $13 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $134 | $470 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
40 | $6 | $30 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
40 | $5 | $30 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
37 | $89 | $389 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
37 | $40 | $138 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
35 | $109 | $450 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $95 | $522 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
31 | $7 | $23 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $96 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,831
Total received (2022-2024)
Avg $944/year across 3 years
Top 32% in MA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
125
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,831 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,375
2023
$1,272
2022
$184
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$339
Amgen Inc.
$199
Lilly USA, LLC
$186
Novo Nordisk Inc
$165
Alexion Pharmaceuticals, Inc.
$76
Novartis Pharmaceuticals Corporation
$63
AstraZeneca Pharmaceuticals LP
$48
Xeris Pharmaceuticals, Inc.
$46
Mannkind Corporation
$46
Bayer Healthcare Pharmaceuticals Inc.
$35
ABBVIE INC.
$34
Esperion Therapeutics, Inc.
$29
Amneal Pharmaceuticals LLC
$24
Kyowa Kirin, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Abbott Laboratories
$22
Tandem Diabetes Care, Inc.
$17
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2022-2024) ›
Lilly USA, LLC
$551
Novo Nordisk Inc
$494
Corcept Therapeutics
$373
Amgen Inc.
$199
SANOFI-AVENTIS U.S. LLC
$149
Alexion Pharmaceuticals, Inc.
$122
AstraZeneca Pharmaceuticals LP
$118
ABBVIE INC.
$100
Novartis Pharmaceuticals Corporation
$95
Bayer Healthcare Pharmaceuticals Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Xeris Pharmaceuticals, Inc.
$62
Kyowa Kirin, Inc.
$51
Mannkind Corporation
$46
Abbott Laboratories
$45
Tandem Diabetes Care, Inc.
$44
Medtronic, Inc.
$42
Merck Sharp & Dohme LLC
$40
Horizon Therapeutics plc
$31
Esperion Therapeutics, Inc.
$29
Amneal Pharmaceuticals LLC
$24
Amryt Pharma Holdings Ltd
$22
MannKind Corporation
$22
Dexcom, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$16
Top 3 companies account for 50.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Crysvita · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · HUMULIN · JANUMET · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · NEXLETOL · Ozempic · RECORLEV · Repatha · Rybelsus · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNTHROID · TEPEZZA · TZIELD · UNITHROID · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
44
Per 100K population
7.6
County median income
$84,198
Nearest hospital
SAINT ANNE'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kubbar is a clinical cardiology specialist, with above-average Medicare volume (top 13% in MA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kubbar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kubbar performed 533 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kubbar receive payments from pharmaceutical companies?
Yes. Dr. Kubbar received a total of $2,831 from 25 companies across 125 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kubbar's costs compare to other endocrinologists in Fall River?
Dr. Kubbar's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kubbar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Fall River
Browse endocrinologists in Fall River ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MA
Which MA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology